Uche Mordi, PharmD, MS

Gilead Sciences

Poster(s):

• (252) Treatment switch among Medicare-insured people with human immunodeficiency virus and gaps in care
  Wednesday, October 29, 2025

• (253) Treatment switch among United States Medicare beneficiaries with human immunodeficiency virus
  Wednesday, October 29, 2025

• (254) Antiretroviral therapy persistence among treatment-experienced people with human immunodeficiency virus and mental health disorders in the United States
  Wednesday, October 29, 2025

• (255) Antiretroviral therapy persistence following a change or restart in regimen among people with HIV
  Wednesday, October 29, 2025